
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : YP05002
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase I
Sponsor : Pfizer Inc
Deal Size : $2085.0 million
Deal Type : Collaboration
Fosun Pharma's Yao Pharma, Pfizer in Exclusive Collaboration & License Agreement
Details : The collaboration aims to advance YP05002, a small molecule product, targeting GLP-1R.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : $150.0 million
December 09, 2025
Lead Product(s) : YP05002
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase I
Sponsor : Pfizer Inc
Deal Size : $2085.0 million
Deal Type : Collaboration
